Novartis lands assets from inflammation specialist IFM Acquisitions, Atherosclerosis, Business, Deals, Fatty liver disease (NASH), Gout, Immune System, Immunology, Inflammation, Inflammatory Bowel Disease, Inflammatory Disorders Novartis agreed to pay $310 million upfront, with the possibility for more later, for some research assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker expands the company’s immunology pipeline. Read more April 1, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-04-01 02:29:482019-04-01 13:10:25Novartis lands assets from inflammation specialist IFM
